Skip to content

SABS

SAB Biotherapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.60
+2.77%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
1892.52x

Trailing multiples

Trailing twelve months

P/E TTM
0.73x
PEG TTM
—
Price / book
1.10x
Price / sales
—
Price / cash flow
-3.47x

Enterprise value

Enterprise value
$139.1M
EV / sales
—
EV / EBITDA
-14.75x
EV / EBIT
-1.94x
Market cap
$236.6M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026